Adjuvant Intravesical Mitoxantrone After Transurethral Resection of Primary Superficial Transitional Cell Carcinoma of the Bladder. A Prospective Randomised Study

Author： Flamm J.   Donner G.   Oberleitner S.   Hausmann R.   Havelec L.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.2, 1995-01, pp. : 143-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is the available evidence to support immediate adjuvant intravesical chemotherapy after transurethral resection of superficial transitional cell carcinoma of the bladder? - Phase III study of intravesical instillation of epirubicin, BCG tice and BCG tice plus isoniazid in intermediate and high risk TaT1 papillary carcinoma of the bladder

By Schellhammer P.F.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 3, 1998-05 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients

By Milla Paola   Fiorito Chiara   Soria Francesco   Arpicco Silvia   Cattel Luigi   Gontero Paolo  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 503-509

Springer Publishing Company

Access to resources Recommend Favorite

Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer - a prospective study

By Knapp D.W.   Glickman N.W.   DeNicola D.B.   Bonney P.L.   Lin T.L.   Glickman L.T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 2, 2000-03 ,pp. : 47-59

Elsevier

Access to resources Recommend Favorite

Randomized Intergroup Comparison of Bacillus Calmette-Guerin Immunotherapy and Mitomycin C Chemotherapy Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder - A Southwest Oncology Group Study

By Lamm D.L.   Blumenstein B.A.   Crawford E.D.   Crissman J.D.   Lowe B.A.   Smith J.A.   Sarosdy M.F.   Schellhammer P.F.   Sagalowsky A.I.   Messing E.M.   Loehrer P.   Grossman H.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 3, 1995-05 ,pp. : 119-126

Elsevier

Access to resources Recommend Favorite

Differential C-erbB-2 and VEGF expression following BCG immunotherapy in superficial papillary transitional cell carcinoma of the bladder

By Morgan B.E.   Salup R.   Morgan M.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite